Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› Milan
Clinical trial register · Italy

Clinical Trials in Milan, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Italy and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 6778 matching records held by the registry are in this view. Synced 08 Oct 2026, 03:19 UTC
6778
Studies in scope
all four open statuses
4069
Recruiting now
open to new participants
1018
Lead sponsors
across recruiting studies
Top sites
Ranica 18 Bergamo 14 Milan 10 Alessandria 5 Brescia 5
Narrow the registerReset
Recruitment status
Phase
Site location
Ranica18 Bergamo14 Milan10 Alessandria5 Brescia5
All 51 locations
Target enrolment
to

Trials with a site in Milan

10 of 6778 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Italy
Start
Not yet open
Mario Negri Institute for Pharmacological Research
Phase 2
150
Milan
2026-04-30
Recruiting
RESOLving INflammation Through Diet for Health (RESOLVIN)
NCT07331103Cardiovascualr Disease, Lipids, Inflammation, n-3 Polyunsatured Fatty Acids (n-3 PUFA)
Mario Negri Institute for Pharmacological Research
Not applicable
324
Avellino, Arese, Milan, Paderno Dugnano, Matera
2025-11-26
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2
21
Brescia, Florence, Genova, Milan, Padova, Parma
2025-08-07
Recruiting
Mario Negri Institute for Pharmacological Research
Phase 2/3
246
Brescia, Bergamo, Milan, Naples, Novara, Padova, Palermo, Pergine Valsugana
2025-03-26
Recruiting
Mario Negri Institute for Pharmacological Research
Observational
300,000
Milan, Catania, Orbassano, Pozzuoli, Torino, Vercelli
2024-10-01
Active, closed
Mario Negri Institute for Pharmacological Research
Phase 4
190
San Fermo della Battaglia, Brescia, Florence, Lecco, Lucca, Milan, Padova, Parma
2023-09-15
Recruiting
CardioPulmonary Resuscitation With Argon (CPAr) Trial
NCT05482945Cardiac Arrest, Out-Of-Hospital, Cardiac Arrest With Successful Resuscitation
Mario Negri Institute for Pharmacological Research
Phase 2
120
Genova, Monza, Milan, Parma, Pordenone, Reggio Emilia, Roma, Trento
2022-05-30
Recruiting
Health-care Quality in Semi-intensive Care Units
NCT04676347Semi-intensive Care Unit, Evaluation, Quality
Mario Negri Institute for Pharmacological Research
Observational
39,000
Milan, Alessandria, Bassano del Grappa, Bologna, Catania, Cesena, Livorno, Lodi
2021-07-01
Active, closed
Mario Negri Institute for Pharmacological Research
Observational
1,200
Milan
2020-09-15
Active, closed
NASCITA Italian Birth Cohort Study
NCT03894566Social Determinants of Health, Health Knowledge, Attitudes, Practice, Development, Child, Mental Disorders
Mario Negri Institute for Pharmacological Research
Observational
5,000
Milan
2019-04-01
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Italian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 10 October 2026. https://priyalifescience.com/clinical-trials-italy/city/milan

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Italy and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 6,778 studies in total at the last sync on 08 Oct 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Milan that also match the filters currently applied.

How many clinical trials are recruiting in Milan?

6 of the 10 studies on this page are recruiting new participants as of the 08 Oct 2026, 03:19 UTC sync. A further 1 have not yet opened recruitment, 3 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Milan), 10 studies
PhaseStudiesRecruitingShare
Observational4240%
Phase 23230%
Not applicable1110%
Phase 2/31110%
Phase 41010%

Most active sponsors

Lead sponsors with the most studies (Milan)
Lead sponsorStudiesRecruiting
Mario Negri Institute for Pharmacological Research106
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.